GENE ONLINE|News &
Opinion
Blog

2025-11-26|

Study Finds High Prevalence of Intestinal Schistosomiasis Among Children Near Mai-Nigus Irrigation Dam in Northern Ethiopia

by GOAI
Share To

A recent study published in BMC Pediatrics examined the prevalence and risk factors of intestinal schistosomiasis among school-age children living near the Mai-Nigus irrigation dam in Tigray, northern Ethiopia. Researchers T.A. Yanshet, G. Gebrezgabiher, and M. Birmeka conducted the study to better understand how proximity to irrigation infrastructure impacts the spread of this parasitic disease in vulnerable populations.

The findings highlight significant health concerns for children residing near the dam, where environmental conditions may facilitate transmission of schistosomiasis. The study identified key risk factors associated with infection, including frequent contact with contaminated water sources and limited access to sanitation facilities. Researchers emphasized that these conditions create an environment conducive to the spread of Schistosoma parasites, which are responsible for intestinal schistosomiasis. The study provides valuable data on disease prevalence and underscores the importance of addressing waterborne diseases in communities reliant on irrigation systems for agriculture and daily life.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top